Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Horizon Therapeutics (NQ: HZNP ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Horizon Therapeutics < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > S&P 500 Futures Slip After Home Depot's Q1 Print: Analyst Says Retest Of October Lows Likely May 16, 2023 Via Benzinga Vodafone, Calliditas Therapeutics, Rumble And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session May 16, 2023 U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga How Is The Market Feeling About Horizon Therapeutics? May 12, 2023 Via Benzinga Looking At Horizon Therapeutics's Recent Unusual Options Activity May 10, 2023 Via Benzinga Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) May 10, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics's Return On Capital Employed Overview May 08, 2023 Via Benzinga Here's How Much You Would Have Made Owning Horizon Therapeutics Stock In The Last 10 Years May 04, 2023 Via Benzinga Merger-Bound Horizon Therapeutics' Q1 Earnings Miss Estimates May 03, 2023 Via Benzinga Horizon Therapeutics: Q1 Earnings Insights May 03, 2023 Via Benzinga Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by U.S. Patient Advocacy Groups May 09, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc (“Horizon”) - Rule 2.12 Announcement May 04, 2023 From Horizon Therapeutics plc Via Business Wire Why Amgen Stock Was Sickly Today May 03, 2023 The company's asset-to-be reported underwhelming first-quarter results. Via The Motley Fool Horizon Therapeutics plc Reports First-Quarter 2023 Financial Results May 03, 2023 From Horizon Therapeutics plc Via Business Wire A Look Into Horizon Therapeutics' Debt April 28, 2023 Via Benzinga A Look Into Horizon Therapeutics Inc's Price Over Earnings April 27, 2023 Via Benzinga Here's How Much You Would Have Made Owning Horizon Therapeutics Stock In The Last 5 Years April 17, 2023 Via Benzinga A Look Into Horizon Therapeutics' Debt April 12, 2023 Via Benzinga Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Lupus Nephritis May 02, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Ranks First in Patient Centricity and Integrity by Patient Advocacy Groups According to New PatientView Survey May 02, 2023 From Horizon Therapeutics plc Via Business Wire Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) May 01, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Announces Initiation of Phase 3 Clinical Trial in Japan Evaluating TEPEZZA® (teprotumumab-trbw) in Adults with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED) May 01, 2023 From Horizon Therapeutics plc Via Business Wire Here's How Much $100 Invested In Horizon Therapeutics 5 Years Ago Would Be Worth Today April 12, 2023 Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session April 28, 2023 Via Benzinga Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks? April 28, 2023 Experts fear a change in how Medicare buys drugs could slam biotech and pharma companies. Via Investor's Business Daily Horizon Therapeutics plc Announces UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the 2023 American Academy of Neurology (AAN) Annual Meeting April 20, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community April 18, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement April 17, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for TEPEZZA® (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease Activity or Duration April 14, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc to Release First-Quarter 2023 Financial Results on May 3, 2023 April 14, 2023 From Horizon Therapeutics plc Via Business Wire Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry April 13, 2023 When billionaires jump on the same trend, it’s important for investors to take notice. The pieces often don’t come together immediately, but these investors have millions of dollars in resources... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
